TECHWIRE 30
(CIX: WRAL30)  1,042.83  up arrow+1.08  (0.1 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: Apple)  99.34  up arrow+1.67  (1.71 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NY: QUINTILES)  54.50  down arrow-0.8  (-1.45 %)  Updated: 01:41 PM EDT, Oct 20 2014
(OP: BASF SE)  86.98  down arrow-1.43  (-1.62 %)  Updated: 01:34 PM EDT, Oct 20 2014
(NQ: BioCryst)  11.60  up arrow+0.02  (0.17 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: BioDelivery)  16.66  up arrow+0.71  (4.45 %)  Updated: 01:40 PM EDT, Oct 20 2014
(NQ: CEMP)  12.31  up arrow+0.06  (0.49 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: Cisco Systems)  22.85  down arrow-0.4  (-1.72 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NQ: Cree)  32.72  down arrow-0.41  (-1.24 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: DARA)  0.85  down arrow-0.02  (-2.11 %)  Updated: 01:34 PM EDT, Oct 20 2014
(NY: EMC CORPORATION)  26.88  down arrow-0.23  (-0.85 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NQ: Extreme Networks)  3.15  up arrow+0.09  (2.77 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NQ: FB)  76.76  up arrow+0.81  (1.07 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NY: GLAXOSMITHKLINE)  43.44  down arrow-0.23  (-0.53 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: GOOG)  516.56  up arrow+5.39  (1.05 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NY: IBM)  169.65  down arrow-12.4  (-6.81 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NY: LH)  98.55  down arrow-0.12  (-0.12 %)  Updated: 01:40 PM EDT, Oct 20 2014
(OP: Lenovo Group)  28.48  up arrow+0.47  (1.67 %)  Updated: 01:36 PM EDT, Oct 20 2014
(NY: MRK)  54.11  up arrow+0.09  (0.17 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NQ: Microsoft Corp)  43.94  up arrow+0.31  (0.71 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: NTAP)  38.17  down arrow-0.65  (-1.67 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NY: NOVARTIS AG)  87.61  up arrow+0.98  (1.14 %)  Updated: 01:41 PM EDT, Oct 20 2014
(OP: Novozymes A/S)  40.24  up arrow+0.3  (0.75 %)  Updated: 01:22 PM EDT, Oct 20 2014
(NY: PFIZER)  27.79  down arrow-0.04  (-0.14 %)  Updated: 01:42 PM EDT, Oct 20 2014
(NQ: Pozen)  8.17  up arrow+0.05  (0.62 %)  Updated: 01:40 PM EDT, Oct 20 2014
(NY: RED HAT)  56.23  up arrow+0.54  (0.97 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: BBRY)  10.12  up arrow+0.63  (6.63 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: Salix)  141.81  up arrow+1.81  (1.29 %)  Updated: 01:41 PM EDT, Oct 20 2014
(NQ: SQI)  15.28  up arrow+0.24  (1.6 %)  Updated: 01:40 PM EDT, Oct 20 2014

Posts tagged “Biotech & Life Science”

7:01 a.m. today

Review: Your 58 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

6:59 a.m. today

Have news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated October 17

Exec: GSK's Ebola vaccine will 'come too late' for current epidemic

Ebola The head of Ebola vaccine research at GlaxoSmithKline tells the BBC that the company's treatment that is now being tested isn't likely to be "the primary answer to this particular outbreak." He concedes GSK could have moved faster.

October 17

NC award for Bob Ingram; CED's parties; Amazon hiring 80,000; AMD layoffs; FBI warns on phone encryption

Bulldog In today's Bulldog wrapup on technology and life science news: Former GSK exec Bob Ingram to receive NC honor; the CED plans 30th anniversary parties; Amazon is hiring big time; AMD is cutting jobs; and the FBI director warns against cellphone encryption.

Updated October 16

Durham-based Chimerix speeds up Ebola testing

Ebola Chimerix says it has FDA approval to launch a Phase 2 clinical trial of its possible treatment for Ebola. The drug has already been administered to two Ebola patients, one of whom died. The new trial will test safety, tolerability and efficacy for Brincidofovir.

October 16

LabCorp-LipoScience deal advances; Red Hat's new women awards; a comet landing; eBay's miss; NetFlix plunge

Bulldog In today's wrapup of tech and life science news: LabCorp's $85M acquisition of LipoScience clears a key hurdle; Red Hat announces women in Open Source awards; a comet landing is at hand; eBay's miss; and NetFlix stock plunges.

October 15

AskBio, spinouts tackle big diseases with nano technology

AskBio founder R. Jude Samulski, Ph.D. Hemophilia. Duchenne muscular dystrophy. Epilepsy. Alzheimer's disease. Diabetic retinopathy. Age-related macular degeneration. Osteoarthritis. These are just some of the diseases that Chapel Hill-based Asklepios BioPharmaceutical (AskBio) is working to alleviate through the development and delivery of novel, intracellular protein therapeutics using its cutting-edge Biological Nano Particle (BNP) technology.

October 14

Entegrion lands $7.8M from DoD; Zuckerbergs donate $25M for Ebola fight; Bioventus acquires product line; Yelp fights extortion claims

Bulldog In today's Bulldog wrapup of life science and technology news: Entegrion lands $7.8 million Department of Defense contract for platelet development; Zuckerbergs donate to fight Ebola; Bioventus acquires a product line; Yelp fights extortion claims.

October 14

Bioterror threat: 'If I want to attack somebody nowadays, all I need is a plane ticket to an international destination'

Bioterror  At the first "Bio Defense Summit, leaders from across North Carolina discuss the threats of bioterror and how N.C. can secure more federal research and development funds to help head off any future attack on the U.S. The Ebola epidemic has only increased concerns about what a bioterror attack could mean.

October 13

Dallas health worker tests positive for Ebola

Ebola A "breach of protocol" at the hospital where Ebola victim Thomas Eric Duncan was treated before his death led to the infection of a health care worker with the deadly virus, and other caregivers could potentially be exposed, federal health officials said Sunday.

Updated October 13

Making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

October 13

Your 55 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

October 10

#WTWTrends for Friday: Fiber, IoT, Red Hat and Twisty the Clown trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Friday, Oct. 10, 2014 as curated by @WRALTechWire.

Updated October 9

Quintiles exec: Reduce clinical trial timelines to speed up drug, vaccine development

In the midst of the deadly Ebola outbreak and the rushing to trial of experimental treatments, the world's top life sciences services company is calling for faster drug and vaccine development. In a 21st Century Cures Initiative discussion hosted by Rep. Renee Ellmers on Thursday, the head of the Phase 1 Clinical Research Division at Quintiles, said Phase 1 trial "timelines" should be reduced by "addressing inefficiencies and redundancies." Quintiles has helped develop and commercialize all of the world's top 100 selling drugs in 2013.

Developing vaccines Developing vaccines

Updated October 8

Ebola patient treated with experimental drug from Durham firm dies

Ebola Outbreak The first Ebola patient diagnosed in the United States died in a Dallas hospital Wednesday, a little more than a week after his illness exposed gaps in the nation's defenses against the disease and set off a scramble to track down anyone exposed to him.

Updated October 8

Premium Lock Nagoya University's RTP exec: Nobel Prize a 'huge' boost

If you weren't aware that Japan's Nagoya University has a technology transfer and business development office in the Triangle, you should be now. After all, on Tuesday two Nagoya professors shared the Nobel Prize for Physics. The award "surely will increase our reputation" as Nagoya seeks more deals, says its RTP executive.

A blue LED as invented by Nagoya U. professors A blue LED as invented by Nagoya U. professors

Updated October 8

Lenovo class-action suit; new GSK probe; AT&T data breach; Salix drug wins OK; Facebook's anonymous app; Lenovo-NEC deal

Bulldog In today's Bulldog blog wrapping up the latest technology and life science news: Lenovo settles a class-action suit over Wi-Fi; GSK faces another bribery investigation; AT&T data breach; FDA OKs Salix colitis treatment; Facebook is developing an app for anonymous posts; and Lenovo extends its partnership with NEC.

October 8

Journalist stricken with Ebola also receives experimental Chimerix drug

Ebola Outbreak Durham-based Chimerix is providing its experimental antiviral drug to a journalist in Nebraska. A Dallas patient also being treated for Ebola received the treatment earlier.

October 7

#WTWTrends for Tuesday: Nobel Prize, Chimerix, INC and Canes trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Tuesday, Oct. 7, 2014 as curated by @WRALTechWire.

Updated October 7

Raleigh-based INC Research files for $150M IPO

INC Research, a life science services firm based in Raleigh, is the latest Triangle firm seeking to go public on Wall Street. It's looking to raise some $150 million. INC lost money in 2013 but is in the black so far in 2014, according to its IPO filing.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll